
SBC Medical Group rose 103.6% from $3.04 to $6.18, ahead of the S&P 500's +11.2%. Its worst day was Apr 20 (−17.1%), and its low came May 18 at $2.87.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.14 beat the $0.12 estimate on $39.6M revenue (est. $46.1M).
+4.2% · S&P 500 −1.7%
Story events cover the past 12 months · Times ET
SBC Medical Group shares fell 17.1%, while the S&P 500 fell 0.2%.
−17.1%, the year's worst day · S&P 500 −0.2%
EPS of $0.11 beat the $0.10 estimate on $43.1M revenue (est. $41.8M).
−7.7% · S&P 500 +0.8%
EPS of $0.10 missed the $0.12 estimate on $49.2M revenue (est. $45.6M).
−0.3% · S&P 500 +0.7%
EPS of $0.15 beat the $0.12 estimate on $58.6M revenue (est. $49.0M).
+37.6%, the year's best day, on 2M shares, the year's heaviest volume · S&P 500 −0.4%
Where it ended: a close of $6.18 on Nov 16, 2026.
Nothing in the past 12 months.
All SBC dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SBC and SPY from Benzinga historical bars. Not investment advice.